Abstract Details
|
Laurence Mignon, PhD
(Ionis Pharmaceuticals, Inc)
PRESENTER |
No disclosure on file |
| Holly Kordasiewicz | Holly Kordasiewcz has received personal compensation for serving as an employee of Ionis. Holly Kordasiewcz has stock in Ionis. |
| Roger M. Lane, MD, MPH (Ionis Pharmaceuticals) | No disclosure on file |
| Anne Smith (Isis Pharmaceuticals) | Anne Smith has received personal compensation for serving as an employee of Ionis Pharmaceuticals. |
| Timothy M. Miller, MD, PhD (Washington University) | Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Bio. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Eric Swayze, PhD (Isis Pharmaceuticals) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Frank Bennett, PhD | No disclosure on file |